Physician Assistant Program year 2024 Reported 2021–2024 Source: CMS Open Payments, 2026 publication

Carissa Spain

Physician Assistant Maquoketa, IA Physician Assistant

NPI 1053656116 CMS profile 10427103

206 N Arcade St, Maquoketa, IA 52060

Open in the dashboard

General payments

$2,499

171 records reported · program years 2021–2024

Research payments

$0

Paid to them · None reported · program years 2021–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Carissa Spain of Maquoketa, IA is reported in the CMS Open Payments database as having received $2,499 across 171 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 83rd percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $166 11
2023 General $791 53
2022 General $636 41
2021 General $907 66

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Carissa Spain
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Carissa Spain were reported at $0. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Carissa Spain Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $907 $132 $37–$438 $132
2022 $636 $155 $48–$522 $149
2023 $791 $167 $52–$557 $160
2024 $166 $178 $55–$600 $164
2025 $0 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2024
  1. Pfizer Inc. $389 33 payments
  2. Amgen Inc. $279 20 payments
  3. Novo Nordisk Inc $261 16 payments
  4. AstraZeneca Pharmaceuticals LP $197 14 payments
  5. Astellas Pharma US Inc $169 10 payments
  6. AbbVie, Inc. $167 8 payments
  7. Mylan Specialty L.P. $112 8 payments
  8. Boehringer Ingelheim Pharmaceuticals, Inc. $102 6 payments
  9. Novartis Pharmaceuticals Corporation $99 6 payments
  10. Janssen Pharmaceuticals, Inc $97 7 payments
  11. Other $627 43 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2024
  1. Food and Beverage $2,499 171 payments
Products named General payments · program years 2021–2024
  1. Ozempic $210 13 payments
  2. Repatha $194 13 payments
  3. Otezla $152 10 payments
  4. ELIQUIS $135 10 payments
  5. BREZTRI $134 9 payments
  6. PREMARIN $129 11 payments
  7. RYBELSUS $128 8 payments
  8. NURTEC ODT $124 11 payments
  9. YUPELRI $112 8 payments
  10. UBRELVY $103 5 payments
  11. Other $2,784 195 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 50 drugs

Part D claims

1,293

Median for Physician Assistant: 241

Drug cost

$68,815

Median for Physician Assistant: $4,110

Branded share of claims

19.2%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ozempic Semaglutide Brand 30 $32,779
Farxiga Dapagliflozin Propanediol Brand 30 $21,124
Potassium Chloride Generic 33 $1,657
Midodrine Hcl Generic 14 $1,518
Omeprazole Generic 69 $1,075
Ezetimibe Generic 24 $1,007
Atorvastatin Calcium Generic 104 $864
Metoprolol Succinate Generic 43 $744
Rosuvastatin Calcium Generic 68 $740
Albuterol Sulfate Hfa Albuterol Sulfate Brand 27 $650

The 10 drugs with the highest cost, of 50 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 59 billing codes

Paid by Medicare

$39,599

Of which drugs: $17,569

Medicare patients

138

Average age 74

Services billed

1,900

107 women, 31 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 72%
Arthritis 38%
Osteoporosis 30%
Diabetes 25%
Chronic kidney disease 20%
Ischemic heart disease 17%
Depression 17%
Cancer 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 16 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Ozempic
  • Novo Nordisk Inc $23
$23 30 —
MOUNJARO
  • Lilly USA, LLC $18
$18 — —
VYNDAMAX
  • PFIZER INC. $17
$17 — —
Veozah
  • Astellas Pharma US Inc $14
$14 — —
Repatha
  • Amgen Inc. $13
$13 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 16 in the dashboard with a free account

Records

171 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Iowa

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record